10x Genomics(TXG) - 2024 Q2 - Quarterly Results

Exhibit 99.1 10x Genomics Reports Second Quarter 2024 Financial Results Recent Highlights Second Quarter 2024 Financial Results 2024 Financial Guidance Webcast and Conference Call Information PLEASANTON, Calif. August 8, 2024 – 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the second quarter ended June 30, 2024. • Revenue was $153.1 million for the second quarter, a 4% increase over the corresponding period of 2023, primarily driven by st ...